Suppr超能文献

海绵窦内侧壁。第2部分:50例垂体腺瘤患者的选择性内侧壁切除术

The medial wall of the cavernous sinus. Part 2: Selective medial wall resection in 50 pituitary adenoma patients.

作者信息

Cohen-Cohen Salomon, Gardner Paul A, Alves-Belo Joao T, Truong Huy Q, Snyderman Carl H, Wang Eric W, Fernandez-Miranda Juan C

机构信息

Departments of1Neurological Surgery and.

3Department of Neurological Surgery, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.

出版信息

J Neurosurg. 2018 Sep 7;131(1):131-140. doi: 10.3171/2018.5.JNS18595. Print 2019 Jul 1.

Abstract

OBJECTIVE

Pituitary adenomas often invade the medial wall of the cavernous sinus (CS), but this structure is generally not surgically removed because of the risk of vascular and cranial nerve injury. The purpose of this study was to report the surgical outcomes in a large series of cases of invasive pituitary adenoma in which the medial wall of the CS was selectively removed following an anatomically based, stepwise surgical technique.

METHODS

The authors' institutional database was reviewed to identify cases of pituitary adenoma with isolated invasion of the medial wall, based on an intraoperative evaluation, in which patients underwent an endoscopic endonasal approach with selective resection of the medial wall of the CS. Cases with CS invasion beyond the medial wall were excluded. Patient complications, resection, and remission rates were assessed.

RESULTS

Fifty patients were eligible for this study, 15 (30%) with nonfunctional adenomas and 35 (70%) with functional adenomas, including 16 growth hormone-, 10 prolactin-, and 9 adrenocorticotropic hormone (ACTH)-secreting tumors. The average tumor size was 2.3 cm for nonfunctional and 1.3 cm for functional adenomas. Radiographically, 11 cases (22%) were Knosp grade 1, 23 (46%) Knosp grade 2, and 16 (32%) Knosp grade 3. Complete tumor resection, based on intraoperative impression and postoperative MRI, was achieved in all cases. The mean follow-up was 30 months (range 4-64 months) for patients with functional adenomas and 16 months (range 4-30 months) for those with nonfunctional adenomas. At last follow-up, complete biochemical remission (using current criteria) without adjuvant treatment was seen in 34 cases (97%) of functional adenoma. No imaging recurrences were seen in patients who had nonfunctional adenomas. A total of 57 medial walls were removed in 50 patients. Medial wall invasion was histologically confirmed in 93% of nonfunctional adenomas and 83% of functional adenomas. There were no deaths or internal carotid artery injuries, and the average blood loss was 378 ml. Four patients (8%) developed a new, transient cranial nerve palsy, and 2 of these patients required reoperation for blood clot evacuation and fat graft removal. There were no permanent cranial nerve palsies.

CONCLUSIONS

The medial wall of the CS can be removed safely and effectively, with minimal morbidity and excellent resection and remission rates. Further follow-up is needed to determine the long-term results of this anatomically based technique, which should only be performed by very experienced endonasal skull base teams.

摘要

目的

垂体腺瘤常侵犯海绵窦(CS)内侧壁,但由于存在血管和颅神经损伤风险,该结构一般不进行手术切除。本研究的目的是报告一系列侵袭性垂体腺瘤病例的手术结果,这些病例采用基于解剖学的分步手术技术选择性切除CS内侧壁。

方法

回顾作者所在机构的数据库,根据术中评估确定单纯内侧壁受侵的垂体腺瘤病例,这些患者接受了经鼻内镜入路并选择性切除CS内侧壁。排除CS侵犯超出内侧壁的病例。评估患者的并发症、切除率和缓解率。

结果

50例患者符合本研究标准,15例(30%)为无功能腺瘤,35例(70%)为功能性腺瘤,包括16例生长激素分泌型、10例催乳素分泌型和9例促肾上腺皮质激素(ACTH)分泌型肿瘤。无功能腺瘤的平均肿瘤大小为2.3 cm,功能性腺瘤为1.3 cm。影像学检查显示,11例(22%)为Knosp 1级,23例(46%)为Knosp 2级,16例(32%)为Knosp 3级。根据术中印象和术后MRI,所有病例均实现了肿瘤全切。功能性腺瘤患者的平均随访时间为30个月(范围4 - 64个月),无功能腺瘤患者为16个月(范围4 - 30个月)。在最后一次随访时,34例(97%)功能性腺瘤患者在未接受辅助治疗的情况下实现了完全生化缓解(根据当前标准)。无功能腺瘤患者未见影像学复发。50例患者共切除57个内侧壁。组织学证实93%的无功能腺瘤和83%的功能性腺瘤存在内侧壁侵犯。无死亡病例和颈内动脉损伤,平均失血量为378 ml。4例患者(8%)出现新的短暂性颅神经麻痹症状,其中2例患者因血凝块清除和脂肪移植取出需要再次手术。无永久性颅神经麻痹。

结论

CS内侧壁能够安全有效地切除,并发症发生率低,切除率和缓解率良好。需要进一步随访以确定这种基于解剖学技术的长期结果,该技术应由经验丰富的经鼻颅底手术团队实施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验